Pregabalin Capsule 150 mg (Pregabalin)

Adult dose

This medication is to be administered orally without regard to meals, divided into two doses daily. 1. Neuropathic Pain - Peripheral neuropathic pain: initial dose of 150 mg daily, may be increased to 300 mg daily 3 to 7 days later, and may be increased up to a maximum of 600 mg at 7-day intervals if necessary. - Central neuropathic pain: initial dose of 150 mg daily, may be increased to 300 mg daily after 1 week.

Child dose

There is insufficient safety and efficacy data for children under 12 years and adolescents aged 12-17, thus administration is not recommended.

This medication may increase the risk of suicidal thoughts or behaviors, so patients should immediately inform their healthcare provider of any changes in mood or behavior during treatment. Patients who are hypersensitive to this medication should not use it. Diabetic patients might experience weight gain after taking this medication, which may require adjustments to their blood sugar control medication dosage. If allergic reactions or angioedema symptoms occur, the medication should be discontinued immediately. Elderly patients should be cautious as dizziness or drowsiness may increase the risk of falls or injuries. Transient visual disturbances or changes in vision may occur; if symptoms are severe, consultation with a doctor is advised. Abrupt discontinuation of this medication may lead to withdrawal symptoms such as insomnia, headaches, and anxiety, so it should be tapered off under a physician's guidance. Patients with a history of substance abuse should exercise particular caution when using this medication, monitoring for misuse or dependency symptoms. Patients with impaired kidney function may require dose adjustments. Patients with severe heart disease should use this medication with caution. Concomitant use with other drugs that have central nervous system depressant effects may pose a risk of respiratory depression. During early pregnancy, this medication may affect the fetus, so it is advisable for pregnant women not to use it, and fertile women should employ effective contraception. Lactating women should consider discontinuing breastfeeding or the medication since it may be passed into breast milk. As this medication can cause dizziness and drowsiness, patients should avoid driving or operating hazardous machinery after taking it. In cases of overdose, symptoms such as confusion, drowsiness, and depression may occur, and treatment such as hemodialysis may be necessary if required. This medication should be kept out of reach of children and should not be transferred to another container.

Serious side effects

Hives, severe swelling (edema), angioedema, facial swelling, swelling around the mouth and upper respiratory tract, chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, oral/ocular mucosal pain, Stevens-Johnson syndrome, toxic epidermal necrolysis, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough and fever, yellowing of skin or eyes (jaundice), pronounced lethargy.

Mild side effects

• Dizziness
• drowsiness
• confusion
• disturbances in spatial sense
• irritability
• depression
• euphoria
• decreased libido
• insomnia
• depersonalization

This medication should be stored in a tightly closed container to prevent air or moisture from entering, and it is safest to keep it at room temperature between 15 degrees and 30 degrees Celsius. Storing it in this manner helps maintain its effectiveness for a long time.

Appearance

A hard capsule containing white powder with a white upper part and a white lower part.

Package unit

30 capsules/bottle, 300 capsules/bottle